AdvanCell

AdvanCell is a Sydney-based radiopharmaceutical and biotechnology company. It has raised $439.4M across 3 funding rounds, most recently a $315M Series D in 2026, from investors including T. Rowe Price, Abingworth and SV Health Investors.

Key facts

Open roles at AdvanCell

  1. Senior Translational ScientistTranslational Research Institute, Brisbane, QLD, AU
  2. Senior Radiochemist, R&D Technical Development (Pb212 isotope)Richlands, Brisbane, QLD, AU
  3. US Site Quality LeadAndover, MA
  4. US Director, Health Safety & Environment (HSE)Andover, MA
  5. Director, Clinical-Translational ScienceBrisbane, QLD, Australia
  6. Director, CMC – Precursor Development & ManufacturingBoston, MA
  7. Director, CMC – Radiopharmaceutical Process DevelopmentBoston, MA
  8. Associate Director, CMC – Analytical DevelopmentBoston, MA
  9. Associate Director, Trial Operations & BudgetBoston, MA
  10. Director of FacilitiesRichlands, Brisbane, QLD, AU
  11. Senior Scientist, Radiochemical SeparationsRichlands, Brisbane, QLD, AU

Browse AdvanCell roles by location: Boston, United States · Australia

Land a role at AdvanCell

publicOpen roles & company overview

Every live role, the locations AdvanCell hires across, and the company facts — all above.

membersAlerts & tailored applications

An email the day AdvanCell posts a role, a cover letter and résumé bullets tailored to each one, and one-click apply.

Get started

Email & phone for AdvanCell are shown to signed-in members. Sign in →